Taylor DL - Search Results

1

Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cells.

Clayman GL, Taylor DL, Liu FJ, Lavedan P, Savage HE, Schantz SP. Clayman GL, et al. Among authors: taylor dl. Laryngoscope. 1993 Mar;103(3):299-307. doi: 10.1288/00005537-199303000-00010. Laryngoscope. 1993. PMID: 7680086

2

The in vivo biologic effect of interleukin 2 and interferon alfa on natural immunity in patients with head and neck cancer.

Schantz SP, Clayman G, Racz T, Grimm EA, Liu FJ, Lavedan P, Taylor D, Pellegrino C, Savage H. Schantz SP, et al. Arch Otolaryngol Head Neck Surg. 1990 Nov;116(11):1302-8. doi: 10.1001/archotol.1990.01870110074009. Arch Otolaryngol Head Neck Surg. 1990. PMID: 2242261

3

The relationship of circulating IgA to cellular immunity in head and neck cancer patients.

Schantz SP, Liu FJ, Taylor D, Beddingfield N, Weber RS. Schantz SP, et al. Laryngoscope. 1988 Jun;98(6 Pt 1):671-8. doi: 10.1288/00005537-198806000-00019. Laryngoscope. 1988. PMID: 3259661

4

Acute-phase proteins in patients with head and neck cancer treated with interleukin 2/interferon alfa.

Clayman GL, Liu FJ, Savage HE, Taylor DL, Lavedan P, Buchsbaum RM, Pellegrino C, Trujillo JM, Young G, Schantz SP. Clayman GL, et al. Among authors: taylor dl. Arch Otolaryngol Head Neck Surg. 1992 Jan;118(1):41-8. doi: 10.1001/archotol.1992.01880010045014. Arch Otolaryngol Head Neck Surg. 1992. PMID: 1370199

5

Detection of regulatory factors of lymphokine-activated killer cell activity in head and neck cancer patients treated with interleukin-2 and interferon alpha.

Clayman GL, Young G, Taylor DL, Savage HE, Lavedan P, Schantz SP. Clayman GL, et al. Among authors: taylor dl. Ann Otol Rhinol Laryngol. 1992 Nov;101(11):909-15. doi: 10.1177/000348949210101105. Ann Otol Rhinol Laryngol. 1992. PMID: 1444098 Clinical Trial.

6

The analysis of natural killer cell activity by flow cytometry.

Racz T, Sacks P, Van NT, Taylor DL, Young G, Bugis S, Savage HE, Schantz SP. Racz T, et al. Among authors: taylor dl. Arch Otolaryngol Head Neck Surg. 1990 Apr;116(4):440-6. doi: 10.1001/archotol.1990.01870040062015. Arch Otolaryngol Head Neck Surg. 1990. PMID: 1690553

7

Immunomodulation of the induction phase of lymphokine-activated killer activity by acute phase proteins.

Clayman GL, Liu FJ, Taylor DL, Savage HE, Lavedan P, Buchsbaum RM, Trujillo JM, Schantz SP. Clayman GL, et al. Among authors: taylor dl. Otolaryngol Head Neck Surg. 1991 Jul;105(1):26-34. doi: 10.1177/019459989110500104. Otolaryngol Head Neck Surg. 1991. PMID: 1715542

8

Natural killer cell lysis of head and neck cancer.

Racz T, Sacks PG, Taylor DL, Schantz SP. Racz T, et al. Among authors: taylor dl. Arch Otolaryngol Head Neck Surg. 1989 Nov;115(11):1322-8. doi: 10.1001/archotol.1989.01860350056015. Arch Otolaryngol Head Neck Surg. 1989. PMID: 2679794

9

Natural killer cells and metastases from pharyngeal carcinoma.

Schantz SP, Savage HE, Racz T, Taylor DL, Sacks PG. Schantz SP, et al. Among authors: taylor dl. Am J Surg. 1989 Oct;158(4):361-6. doi: 10.1016/0002-9610(89)90134-7. Am J Surg. 1989. PMID: 2802042

10

Differential sensitivity of head and neck cancers to non-major histocompatibility-restricted killer cell activity.

Schantz SP, Racz T, Ordonez NG, Terry N, Taylor DL, Bugis S, Sacks PG. Schantz SP, et al. Among authors: taylor dl. J Surg Res. 1990 Feb;48(2):154-64. doi: 10.1016/0022-4804(90)90208-j. J Surg Res. 1990. PMID: 2106056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

494 results

Search Page

Filters